Charles River Laboratories International (CRL) EBT Margin (2009 - 2026)

Charles River Laboratories International has reported EBT Margin for 18 years, with the latest figure at 5.3% in Q2 2026.

• On a quarterly basis, EBT Margin fell 162.0% year-over-year to 5.3% in Q2 2026; TTM through Jun 2026 was 4.59%, a 414.0% decrease from a year earlier, with the FY2025 full-year figure at 2.48%, down 478.0% from the prior year.
• EBT Margin was 5.3% for Q2 2026 at Charles River Laboratories International, up from 3.01% in the prior quarter.
• The five-year high for EBT Margin was 22.27% in Q4 2022, with the low at 29.58% in Q4 2025.
• Average EBT Margin over 5 years is 6.61%, with a median of 10.39% recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: EBT Margin surged 419 bps in 2022, then sank 4222 bps in 2024.
• Over 5 years, EBT Margin stood at 22.27% in 2022, then fell by 8 bps to 20.59% in 2023, then plunged by 205 bps to 21.62% in 2024, then plunged by 37 bps to 29.58% in 2025, then jumped by 118 bps to 5.3% in 2026.
• The last three EBT Margin figures came in at 5.3% (Q2 2026), 3.01% (Q1 2026), and 29.58% (Q4 2025), per Business Quant data.